Announcements Trials

Browse Landscape

Status

Unknown 1 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 16 Breast Neoplasms 10 Brain Neoplasms 7 Neoplasms 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Urinary Bladder Neoplasms 3 Spinal Cord Neoplasms 3 Multiple Myeloma 2 Lymphoma, B-Cell 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vasculitis 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocythemia, Essential 1 Thoracic Neoplasms 1 Thoracic Diseases 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Diseases 1 Solid Tumor, Adult 1 Sinusitis 1 Sarcoma 1

Interventions

Doxorubicin 80 Ifosfamide 54 Radiotherapy 43 Filgrastim 41 Gemcitabine 38 Cyclophosphamide 34 Etoposide 26 Vincristine 24 Cisplatin 24 Docetaxel 23 pazopanib 21 Trabectedin 19 Carboplatin 17 pembrolizumab 15 Peripheral Blood Stem Cell Transplantation 14 eribulin 12 Mesna 12 Melphalan 12 Sorafenib 11 Sirolimus 11 Irinotecan 11 Granulocyte Colony-Stimulating Factor 11 Bevacizumab 11 Topotecan 10 Paclitaxel 10 Imatinib Mesylate 10 Chemotherapy, Adjuvant 10 pegfilgrastim 9 Temozolomide 9 Surgical Procedures, Operative 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sarcoma × Magnetic Resonance Imaging × Clear all

NCT03658343 2025-02-21

T2* MRI Analysis for Sarcoma

University of Iowa

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡